A study released in STEM CELLS Translational Medicine offers hope for those suffering from a chronic, difficult to treat condition called non-tuberculous mycobacteria (NTM) lung infection.
Study shows potential of human mesenchymal stem cells to treat chronic lung infections
A study released today in
STEM CELLS Translational Medicine offers hope for those suffering from a chronic, difficult to treat condition called non-tuberculous mycobacteria (NTM) lung infection. The study describes how researchers at Case Western University developed a new model of NTM lung infection and then used it to show how effective human mesenchymal stem cells (hMSCs) are in treating this condition - and even which donor cells might be best for doing so.
The potential to use human mesenchymal stem cells to treat difficult lung infections is promising. This study shows the ability of using optimal donors to obtain maximum treatment success.